What is the appropriate method to calculate the basal insulin dose for a 70-kilogram patient with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating Basal Insulin Dose

For a 70-kilogram patient with type 2 diabetes, start with 10 units of basal insulin once daily OR calculate 0.1-0.2 units/kg/day (7-14 units), administered at the same time each day. 1

Standard Initial Dosing Algorithm

For Mild-to-Moderate Hyperglycemia (A1C <9%)

  • Start with 10 units once daily as the simplest approach 1
  • Alternative weight-based calculation: 0.1-0.2 units/kg/day 1
    • For a 70 kg patient: 7-14 units once daily 1
  • Continue metformin unless contraindicated 1

For Severe Hyperglycemia (A1C ≥9% or glucose ≥300-350 mg/dL)

  • Use higher starting doses: 0.3-0.5 units/kg/day as total daily insulin 1, 2
    • For a 70 kg patient: 21-35 units total daily dose 1, 2
  • Implement basal-bolus therapy immediately if A1C ≥10-12% with symptomatic/catabolic features 1, 2
    • Split 50% as basal insulin, 50% as prandial insulin divided among meals 1, 2

Titration Protocol

Standard Adjustment Schedule

  • Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL 1
  • Increase by 4 units every 3 days if fasting glucose is ≥180 mg/dL 1
  • Target fasting glucose: 80-130 mg/dL 1
  • If hypoglycemia occurs: reduce dose by 10-20% immediately 1

Critical Threshold Recognition

When basal insulin exceeds 0.5 units/kg/day (35 units for a 70 kg patient), stop escalating basal insulin alone and add prandial insulin instead. 1, 2 Continuing beyond this threshold leads to "overbasalization" with increased hypoglycemia risk without improved control. 1, 2

Clinical signals of overbasalization include: 1, 2

  • Basal dose >0.5 units/kg/day
  • Bedtime-to-morning glucose differential ≥50 mg/dL
  • Episodes of hypoglycemia
  • High glucose variability throughout the day

Special Population Adjustments

High-Risk Patients (Elderly >65 years, Renal Failure, Poor Oral Intake)

  • Start with lower doses: 0.1-0.25 units/kg/day 1, 2
  • For a 70 kg patient: 7-17.5 units once daily 1, 2

Hospitalized Patients

  • Insulin-naive or low-dose home insulin: 0.3-0.5 units/kg/day total, with half as basal 1, 2
    • For a 70 kg patient: 10.5-17.5 units basal insulin 1, 2
  • High-dose home insulin (≥0.6 units/kg/day): reduce total daily dose by 20% upon admission 1, 2

Type 1 Diabetes

  • Total daily insulin: 0.4-1.0 units/kg/day, typically 0.5 units/kg/day for metabolically stable patients 1, 2
    • For a 70 kg patient: 35 units total daily dose 1, 2
  • Basal component: 40-60% of total daily dose (approximately 50%) 1, 2
    • For a 70 kg patient: 17.5 units basal insulin 1, 2

Common Pitfalls to Avoid

  • Never delay insulin initiation in patients not achieving glycemic goals with oral medications—this prolongs hyperglycemia exposure and increases complication risk 1, 2
  • Never discontinue metformin when starting insulin unless contraindicated—the combination provides superior control with less weight gain 1, 2
  • Never continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia—this causes overbasalization 1, 2
  • Never use sliding scale insulin as monotherapy—it treats hyperglycemia reactively rather than preventing it 1, 2

Monitoring Requirements

  • Daily fasting blood glucose monitoring is essential during titration 1
  • Reassess every 3 days during active titration to adjust dose 1, 2
  • Reassess every 3-6 months once stable to evaluate overall glycemic control and A1C 1, 2
  • Consider adding prandial insulin if A1C remains above target after 3-6 months despite achieving fasting glucose goals 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.